Investor Foresite Capital Fund III, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Foresite Capital Fund III, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-02-11 13G/A ACRS / Aclaris Therapeutics, Inc. 6,612,181 4,657,277
2021-02-16 13G/A CBAY / CymaBay Therapeutics, Inc. 3,819,726 3,428,898
2021-02-11 13G/A ACRS / Aclaris Therapeutics, Inc. 2,230,940 6,612,181
2020-10-27 13G ACRS / Aclaris Therapeutics, Inc. 2,230,940 2,230,940
2020-10-26 13G ACRS / Aclaris Therapeutics, Inc. 2,230,940
2020-02-14 13G/A REPL / Replimune Group, Inc. 2,009,312 313,922
2020-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 4,218,359 3,819,726
2019-02-13 13G/A RCUS / Arcus Biosciences, Inc. 4,095,461 2,028,876
2019-02-13 13G/A / Achaogen Inc 2,375,000 2,864,664
2019-02-13 13G/A CBAY / CymaBay Therapeutics, Inc. 2,854,502 4,218,359
2019-01-23 13G REPL / Replimune Group, Inc. 2,009,312
2018-03-23 13G RCUS / Arcus Biosciences, Inc. 4,095,461
2018-02-13 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 4,627,376
2018-02-13 13G/A / Achaogen Inc 2,607,984 2,375,000
2018-02-13 13G/A CBAY / CymaBay Therapeutics, Inc. 2,691,792 2,854,502
2017-11-06 13G CBAY / CymaBay Therapeutics, Inc. 2,691,792
2017-05-05 13G VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 5,000,000
2017-05-05 13G VNAPF / Verona Pharma Plc 5,000,000
2017-04-25 13G FBRX / Forte Biosciences, Inc. 915,000
2017-02-14 13G/A WVE / Wave Life Sciences Ltd. 1,410,689 676,128
2017-02-14 13G/A ALDR / Alder BioPharmaceuticals, Inc. 2,520,067 2,623,724
2016-12-21 13G / Achaogen Inc 2,607,984
2016-11-04 13G ALDR / Alder BioPharmaceuticals, Inc. 2,520,067
2016-02-12 13G/A WVE / Wave Life Sciences Ltd. 1,333,725 1,410,689
2015-11-19 13G WVE / Wave Life Sciences Ltd. 1,333,725
2015-08-04 13G OREX / Orexigen Therapeutics, Inc. 7,153,034